← back to search

Renaud Lopes

University of Edinburgh · GB
Area of research
Cognitive Neuroscience · Psychiatry and Mental health
Research interest
Research interests include Medicine, Stroke (engine), Hyperintensity, Cognition, Neuroimaging, and Cognitive impairment.
h-index
citations
735
works
10
NIH funding
primary concept
email

Recent publications

Strategic white matter hyperintensity locations associated with post-stroke cognitive impairment: A multicenter study in 1568 stroke patients
International Journal of Stroke 2024cited by 17position: middledoi
Clinical and neuroimaging predictors of benzodiazepine response in catatonia: A machine learning approach
Journal of Psychiatric Research 2024cited by 8position: middledoi
White Matter Hyperintensity Volume and Poststroke Cognition: An Individual Patient Data Pooled Analysis of 9 Ischemic Stroke Cohort Studies
Stroke 2023cited by 27position: middledoi
Trial of Deferiprone in Parkinson’s Disease
New England Journal of Medicine 2022cited by 218position: middledoi
Network impact score is an independent predictor of post-stroke cognitive impairment: A multicenter cohort study in 2341 patients with acute ischemic stroke
NeuroImage Clinical 2022cited by 15position: middledoi
Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts
The Lancet Neurology 2021cited by 302position: middledoi
MRI Radiomic Signature of White Matter Hyperintensities Is Associated With Clinical Phenotypes
Frontiers in Neuroscience 2021cited by 23position: middledoi
Preoperative REM Sleep Behavior Disorder and Subthalamic Nucleus Deep Brain Stimulation Outcome in Parkinson Disease 1 Year After Surgery
Neurology 2021cited by 6position: middledoi
Small effect size leads to reproducibility failure in resting-state fMRI studies
bioRxiv (Cold Spring Harbor Laboratory) 2018cited by 13position: middledoi
Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?© Caroline Moreau <i>et al</i> . 2018; Published by Mary Ann Liebert, Inc. This Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Antioxidants and Redox Signaling 2017cited by 106position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ali Amad · Stockholm Resilience Centre1 papers (2024–2024)Steven Williams · Columbia University1 papers (2024–2024) · 1 papers (2024–2024)Jean‐Pierre Pruvo · Ludwig-Maximilians-Universität München1 papers (2024–2024)J. Matthijs Biesbroek · Utrecht University1 papers (2024–2024)Julie Staals · Maastricht University Medical Centre1 papers (2024–2024)Peter J. Koudstaal · Erasmus MC1 papers (2024–2024)Rong Fang · LMU Klinikum1 papers (2024–2024)Thibaut Dondaine · Ludwig-Maximilians-Universität München1 papers (2024–2024) · 1 papers (2024–2024) · 1 papers (2024–2024) · 1 papers (2024–2024)Nick A. Weaver · Utrecht University1 papers (2024–2024)Hugo J. Kuijf · University Medical Center Utrecht1 papers (2024–2024)Régis Bordet · Netherlands Pharmacovigilance Centre Lareb1 papers (2024–2024)Paul L.M. de Kort · University of Amsterdam1 papers (2024–2024)Floor A.S. de Kort · Utrecht University1 papers (2024–2024)Marco Duering · Southern Medical University1 papers (2024–2024)Robert J. van Oostenbrugge · Leiden University Medical Center1 papers (2024–2024) · 1 papers (2024–2024)